Guerbet is a limited liability company incorporated under the laws of France with securities listed on Euronext Paris, France. Consequently, our corporate governance framework reflects the mandatory provisions of French corporate law, the securities laws and regulations applying to Guerbet as a corporation listed in France States. In addition, the Company’s corporate governance principles refer to the AFEP-MEDEF Code.
On May 21, 2010, Guerbet adopted the French form of a joint stock company governed by a Board of Directors (Société Anonyme à Conseil d'administration). This legal structure upholds a clear separation between management functions assumed by the Executive Committee and the functions of oversight assured by the Board of Directors, which represents the shareholders.
Board of Directors
Marie-Claire Janailhac-Fritsch
Chairwoman of the Board
Carine Dagommer
Director
Olivier Fougère
Employee Director
Mark Fouquet
Director
Eric Guerbet
Director
Didier Izabel
Director
Céline Lamort
Director
Nicolas Louvet
Director
Marc Massiot
Director
Claire Massiot-Jouault
Director
Jean-Sébastien Raynaud
Employee Director
Thibault Viort
Director
Executive Committee
David Hale
Chief Executive Officer
Charlotte Bamière
General Counsel
Jean-François Blanc
SVP Interventional Imaging
Philippe Bourrinet
SVP Development, Medical & Regulatory Affairs and Group Responsible Pharmacist
Valérie Brissart
SVP Diagnostic Imaging
Sarah Dayre
SVP Technical Operations and Interim Responsible Pharmacist
Jérôme Estampes
Chief Financial Officer and SVP Business Development & Licensing
François Nicolas
SVP R&D, R&I and Chief Digital Officer